Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China

© 2020 Wiley Periodicals, Inc..

An outbreak of severe acute respiratory syndrome novel coronavirus (SARS-CoV-2) epidemic spreads rapidly worldwide. SARS-CoV-2 infection caused mildly to seriously and fatally respiratory, enteric, cardiovascular, and neurological diseases. In this study, we detected and analyzed the main laboratory indicators related to heart injury, creatine kinase isoenzyme-MB (CK-MB), myohemoglobin (MYO), cardiac troponin I (ultra-TnI), and N-terminal pro-brain natriuretic peptide (NT-proBNP), in 273 patients with COVID-19 and investigated the correlation between heart injury and severity of the disease. It was found that higher concentration in venous blood of CK-MB, MYO, ultra-TnI, and NT-proBNP were associated with the severity and case fatality rate of COVID-19. Careful monitoring of the myocardiac enzyme profiles is of great importance in reducing the complications and mortality in patients with COVID-19.

Errataetall:

CommentIn: J Med Virol. 2020 Oct;92(10):1747. - PMID 32267000

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:92

Enthalten in:

Journal of medical virology - 92(2020), 7 vom: 17. Juli, Seite 819-823

Sprache:

Englisch

Beteiligte Personen:

Han, Huan [VerfasserIn]
Xie, Linlin [VerfasserIn]
Liu, Rui [VerfasserIn]
Yang, Jie [VerfasserIn]
Liu, Fang [VerfasserIn]
Wu, Kailang [VerfasserIn]
Chen, Lang [VerfasserIn]
Hou, Wei [VerfasserIn]
Feng, Yong [VerfasserIn]
Zhu, Chengliang [VerfasserIn]

Links:

Volltext

Themen:

114471-18-0
Biomarkers
COVID-19
Creatine Kinase, MB Form
Disease severity
EC 2.7.3.2
Heart injury
Journal Article
Laboratory indicators
Myoglobin
Natriuretic Peptide, Brain
Peptide Fragments
Pro-brain natriuretic peptide (1-76)
Research Support, Non-U.S. Gov't
Troponin I

Anmerkungen:

Date Completed 24.06.2020

Date Revised 16.07.2022

published: Print-Electronic

CommentIn: J Med Virol. 2020 Oct;92(10):1747. - PMID 32267000

Citation Status MEDLINE

doi:

10.1002/jmv.25809

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM308185706